All public logs

Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 17:21, 10 February 2015 Gloria Picoy talk contribs uploaded File:Oritavancin Clinical Response Rates in ABSSSI Trials using Responders at 48-72 Hours after Initiation of Therapy.png
• 17:14, 10 February 2015 Gloria Picoy talk contribs uploaded File:Oritavancin Chemical structure.png
• 17:07, 10 February 2015 Gloria Picoy talk contribs uploaded File:Oritavancin Population Mean Plasma Concentration.png
• 17:05, 10 February 2015 Gloria Picoy talk contribs uploaded File:Oritavancin Mean PK parameters.png
• 17:00, 10 February 2015 Gloria Picoy talk contribs uploaded File:Oritavancin Adverse reactions.png
• 18:52, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride structure.png
• 17:35, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride 250 mg.png
• 17:35, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride 750 mg.png
• 17:30, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Clinical Response Rates in Trials 1 and 2 – AT and CE Populations.png
• 17:29, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride All-Cause Mortality at Day 28 in Patients with at least One Baseline Gram-Positive Pathogen.png
• 17:26, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Clinical Cure Rates at the Test-of-Cure for the Most Common Pathogens in cSSSI Trials 1 and 2.png
• 17:25, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Clinical Cure at Test-of-Cure in cSSSI Trials 1 and 2.png
• 17:24, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Baseline Infection Types in Patients in cSSSI.png
• 17:19, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride pharmacokinetics.png
• 17:17, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride pharmacodynamics.png
• 17:14, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride HABP-VABP adverse reactions.png
• 17:12, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride HABP-VABP.png
• 17:10, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Complicated Skin and Skin Structure Infections.png
• 17:06, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Coagulation Tests Affected and Unaffected by Telavancin.png
• 17:04, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride Decreased Clinical Response in Patients with cSSSI and Pre-existing Renal Impairment.png
• 17:01, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride FDA package label.png
• 16:46, 9 February 2015 Gloria Picoy talk contribs uploaded File:Telavancin hydrochloride chemical structure.png
• 16:08, 9 February 2015 Gloria Picoy talk contribs uploaded File:Pyrantel pamoate structure.png
• 16:05, 9 February 2015 Gloria Picoy talk contribs uploaded File:Pyrantel pamoate 32 fl. oz. (946 mL).png
• 16:00, 9 February 2015 Gloria Picoy talk contribs uploaded File:Pyrantel pamoate FDA package label.png
• 14:37, 9 February 2015 Gloria Picoy talk contribs uploaded File:Cefotetan disodium structure.png
• 14:35, 9 February 2015 Gloria Picoy talk contribs uploaded File:Cefotetan disodium 10 mg.png
• 14:24, 9 February 2015 Gloria Picoy talk contribs uploaded File:Cefotetan disodium FDA package label.png
• 13:52, 9 February 2015 Gloria Picoy talk contribs uploaded File:Cefotetan disodium plasma concentrations.png
• 13:47, 9 February 2015 Gloria Picoy talk contribs uploaded File:Cefotetan disodium chemical structure.png
• 20:45, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor structure.png
• 20:41, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor 24 mg.png
• 20:37, 6 February 2015 Gloria Picoy talk contribs uploaded a new version of File:Plerixafor Study 2 Efficacy Results – Mobilization in Multiple Myeloma Patients.png
• 20:37, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Study 2 Efficacy Results – Mobilization in Multiple Myeloma Patients.png
• 20:35, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Efficacy Results - Mobilization in NHL Patients.png
• 20:32, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Study 2 Efficacy Results – Proportion of Patients by Apheresis Day in MM Patients.png
• 20:31, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Study 2 Efficacy Results – CD34+ Cell Mobilization in Multiple Myeloma Patients.png
• 20:28, 6 February 2015 Gloria Picoy talk contribs uploaded a new version of File:Plerixafor Study 1 Efficacy Results – Proportion of Patients by Apheresis Day in NHL Patients.png
• 20:28, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Study 1 Efficacy Results – Proportion of Patients by Apheresis Day in NHL Patients.png
• 20:25, 6 February 2015 Gloria Picoy talk contribs deleted page File:Plerixafor Efficacy Results - CD34+ Cell Mobilization in NHL Patients.png (Deleted old revision 20150206202527!Plerixafor_Efficacy_Results_-_CD34+_Cell_Mobilization_in_NHL_Patients.png)
• 20:25, 6 February 2015 Gloria Picoy talk contribs uploaded a new version of File:Plerixafor Efficacy Results - CD34+ Cell Mobilization in NHL Patients.png
• 20:24, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Efficacy Results - CD34+ Cell Mobilization in NHL Patients.png
• 20:22, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor FDA package label.png
• 20:10, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Pharmacodynamics.png
• 20:07, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor structural formula.png
• 19:58, 6 February 2015 Gloria Picoy talk contribs uploaded File:Plerixafor Adverse reactions.png
• 17:47, 6 February 2015 Gloria Picoy talk contribs uploaded File:Saquinavir mesylate structure.png
• 17:37, 6 February 2015 Gloria Picoy talk contribs uploaded File:Saquinavir mesylate FDA package label.png
• 17:36, 6 February 2015 Gloria Picoy talk contribs uploaded File:Saquinavir mesylate 200 mg.png
• 17:36, 6 February 2015 Gloria Picoy talk contribs uploaded File:Saquinavir mesylate Drug image.png